Ivy Medical Chemicals PlcTo download protocol for the Hungarian Clinical Trial in English:
Pdf file: Protocol for the Hungarian dog study in English
Letölthetö, hivatalosan engedélyezett protokoll rákbeteg kutyák anyagilag szponzorált tanulmányi kezelésére magyarországi állatorvosok által CV 247 készitménnyel:
Pdf file: CV247-protokoll
|
COMPANY OVERVIEWIvy Medical Chemicals plc is an innovative pharmaceutical company whose principal activity is in the development of a patented combination product called CV 247. CV 247 has been the subject of a series of studies in companion animals and human patients to assess its potential as a possible treatment for various cancers and its positive effect on quality of life. The purpose of this web site is to provide information on the constituents of the product together with details of the various studies undertaken. CV 247 is not currently licenced for effect on quality of life or for treating cancers in either animals or humans and no claim is therefore being made on this web site for either efficacy or safety. It is the intention of the company to report the data generated from the different studies undertaken to allow the reader the opportunity to review the information available. The Company is quoted on PLUS Markets and much of its history and activities since 1999 can be viewed in the regulatory announcements by clicking here. CONTACT INFORMATIONTelephone: 0800 0834 753 Email:
This e-mail address is being protected from spambots, you need JavaScript enabled to view it
|
|